PAHC
PHIBRO ANIMAL HEALTH CORP
Nasdaq Pharmaceutical Preparations Accelerated filer

Key Financials

Revenue
$1.3B
↑ 27.4%
Gross Profit
$399.9M
↑ 27.7%
Operating Income
$110.5M
↑ 107.2%
Net Income
$48.3M
↑ 1897.7%
EPS (Diluted)
$1.19
↑ 1883.3%
Total Assets
$1.4B
↑ 38.6%
Total Liabilities
$1.1B
↑ 48.2%
Shareholders' Equity
$285.7M
↑ 11.3%

Recent SEC Filings

Form Type Filed Date Link
4 7/2/2026 View on SEC
8-K 6/26/2026 View on SEC
144 6/16/2026 View on SEC
4 6/2/2026 View on SEC
SCHEDULE 13D/A 5/22/2026 View on SEC
SCHEDULE 13G/A 5/14/2026 View on SEC
4 5/7/2026 View on SEC
8-K 5/6/2026 View on SEC
10-Q 5/6/2026 View on SEC
8-K 5/5/2026 View on SEC

Company Information

Field Value
Ticker PAHC
Company Name PHIBRO ANIMAL HEALTH CORP
CIK 1069899
Sector Pharmaceutical Preparations
Industry Accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 0630
State of Incorporation DE
Phone 201-329-7300